10,636 Shares in Astera Labs, Inc. $ALAB Acquired by Fortis Capital Advisors LLC

Key Points

• Fortis Capital Advisors LLC acquired 10,636 shares of Astera Labs, valued at approximately $962,000, during the second quarter.
• Analysts have raised their price targets for Astera Labs, with Morgan Stanley setting a new target of $200.00 and Bank of America at $230.00, reflecting positive sentiment towards the company's performance.
• Astera Labs reported a 149.5% increase in revenue year-over-year, reaching $191.93 million for the last quarter, significantly exceeding analyst expectations.

Fortis Capital Advisors LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 10,636 shares of the company's stock, valued at approximately $962,000.

A number of other large investors also recently added to or reduced their stakes in ALAB. Fred Alger Management LLC boosted its position in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock valued at $93,087,000 after acquiring an additional 179,638 shares during the last quarter. Hoey Investments Inc. boosted its position in shares of Astera Labs by 22.4% during the 2nd quarter. Hoey Investments Inc. now owns 6,121 shares of the company's stock valued at $553,000 after acquiring an additional 1,121 shares during the last quarter. Wealth Effects LLC bought a new position in shares of Astera Labs during the 2nd quarter valued at approximately $242,000. Sheets Smith Wealth Management bought a new position in shares of Astera Labs during the 2nd quarter valued at approximately $481,000. Finally, Aigen Investment Management LP boosted its position in shares of Astera Labs by 50.9% during the 1st quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock valued at $1,069,000 after acquiring an additional 6,045 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on ALAB. Morgan Stanley increased their price target on Astera Labs from $155.00 to $200.00 and gave the company an "overweight" rating in a report on Friday, August 29th. Susquehanna increased their price target on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Bank of America began coverage on Astera Labs in a report on Friday. They set a "neutral" rating and a $230.00 price target on the stock. Barclays restated an "overweight" rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a report on Thursday, August 7th. Finally, Evercore ISI increased their price target on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $159.83.

Astera Labs Price Performance

ALAB stock opened at $200.74 on Friday. The company has a market capitalization of $33.37 billion, a PE ratio of 358.46, a P/E/G ratio of 5.32 and a beta of 1.43. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The firm's 50-day moving average is $189.83 and its 200 day moving average is $119.14.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. The company had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm's revenue was up 149.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 152,517 shares of the firm's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the transaction, the chief executive officer owned 450,001 shares in the company, valued at approximately $76,648,670.33. This trade represents a 25.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Sanjay Gajendra sold 280,000 shares of the firm's stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total value of $47,605,600.00. Following the transaction, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. This represents a 4.82% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,492,036 shares of company stock worth $232,607,552. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.